Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-359679

Chief Financial Officer acquired 22,807 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
FRATES JAMES M Chief Financial Officer 2026-08-18 Grant or award +22,807 244,435 D
Loading xslF345X06/ownership.xml…